Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.
about
Differences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implicationsInflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological DistinctionRelative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial.Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomasThe prognostic value of age for invasive lobular breast cancer depending on estrogen receptor and progesterone receptor-defined subtypes: A NCDB analysisNeoadjuvant paradigm for accelerated drug development: an ideal model in bladder cancer.Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology.Response to neoadjuvant chemotherapy in ductal compared to lobular carcinoma of the breast: a meta-analysis of published trials including 1,764 lobular breast cancer.Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer.Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy.Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.Issues Affecting the Loco-regional and Systemic Management of Patients with Invasive Lobular Carcinoma of the Breast.An Analysis of Oncotype DX Recurrence Scores and Clinicopathologic Characteristics in Invasive Lobular Breast Cancer.Trends and controversies in multidisciplinary care of the patient with breast cancer.Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant Chemotherapy.MRI and ultrasound evaluation of invasive lobular carcinoma of the breast after primary systemic therapy.Clinicopathological characteristics and survival outcomes of invasive lobular carcinoma in different races.Incidence, risk factors, and outcomes of central venous catheter-related thromboembolism in breast cancer patients: the CAVECCAS study.Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study.TP53 protein levels, RNA-based pathway assessment, and race among invasive breast cancer cases.
P2860
Q26740072-3065E9F1-3B84-4D33-A635-7BA0A92B9C9FQ35890623-11A56353-860B-4233-9D5F-BCE3B4DF15AFQ35998828-20017BEA-24A6-4F44-9793-7EDBC2894688Q36594068-4FAB617D-3756-4FD9-B43A-03E0DA48ABCBQ36905846-02341BFC-F8CF-4226-9A42-43476B740E59Q37128756-5073B27A-B496-4D78-8569-32A51DA4D2CAQ37734922-5EB742A9-53B6-4D6A-9440-B11C1D75000FQ38157648-507C7D43-A71A-416C-B287-5B763965EA39Q38328673-D2B1B553-0D74-4C78-AEFE-82E8188701F6Q38409756-9190562B-34CE-4064-A282-10D00AC44654Q38686027-86A9F70A-38A0-4F5D-9EF4-C6D52FE9C593Q38702293-CB585995-07E8-4211-99B6-BE183ED5C828Q39015485-722780DC-E10A-4EAA-B2AA-F9F817E92116Q39119467-5013F66E-57BA-4B76-80AC-172A37104690Q40179607-5C54DD3E-37B5-4803-954B-7307EADC0B3BQ43471412-67170B64-7DEA-4CEB-AFC7-98B3FC751AF1Q43514504-4D59E2C1-EC7A-480B-BCAB-C24D7743292CQ44823539-670B1CB1-07A7-4BD3-9BB1-2CE63423C558Q48328328-8E3F9590-33EB-490C-A50E-26A2ABB06332Q55287276-BDC9C816-ECFC-47C7-816C-1BA07F2F42E3
P2860
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.
@en
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.
@nl
type
label
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.
@en
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.
@nl
prefLabel
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.
@en
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.
@nl
P2093
P2860
P1476
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer
@en
P2093
Chad Livasy
Christina Yau
Claudette E Loo
Donald A Berry
E Shelley Hwang
Esther H Lips
I-SPY TRIAL Investigators
Jelle Wesseling
Jorma J de Ronde
Laura J Esserman
P2860
P2888
P356
10.1007/S10549-012-2233-Z
P407
P50
P577
2012-09-08T00:00:00Z